Profitelligence Profitelligence · Filing Ledger Open BDX research →

Form 8-K · Current Report · Filed 2026-04-29

Becton, Dickinson Amends By-laws to Update Contested Election Notice Period

On April 28, 2026, Becton, Dickinson and Company's Board of Directors approved amendments to the Company's By-laws.

Filer
Becton, Dickinson and Company BDX · NYSE
Filed
Accession
0000010795-26-000012
CIK
0000010795
Signal
Medium impactHealthcare

Details

The amendments update the advance notice provision to determine the existence of a contested election and include other technical, conforming, and clarifying revisions. The full text of the amended By-laws is filed as Exhibit 3.1.

Items reported

Item events

Reported Item

Bylaw Amendment

Market reaction

Close before filing

$149.52

Next session

-0.3%

Since filing

+10.8%

Latest close

$165.62

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from BDX reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, BDX insiders reported 10 Form 4 transactions — net selling of $535K.

Full BDX insider history →

About Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.

Exchange NYSE Industry Medical Instruments & Supplies Company website ↗

Never miss another BDX filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts